TGFB1 and hypertensive disorder: AgII, a vasoactive peptide, is a key regulator of hypertension, inflammatory response, hypertrophy, and fibrosis through the regulation of multiple signaling pathways, such as NF-κB and TGFβ1/Smad (Shang et al., 2008).